NIDA Notes Archives

This is Archived content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). For current information, please visit nida.nih.gov.

For 30 years, NIDA Notes provided in-depth coverage of research findings on drug misuse and addiction. NIDA Notes was discontinued in 2021.  

Oxycodone Vaccine Passes Early Tests

 |  In preclinical testing, a new vaccine hindered the often-abused prescription opioids oxycodone and hydrocodone from entering the brain and suppressed one of the drugs’ signature central nervous system (CNS) effects...

Q & A: Dr. Redonna Chandler

 |  In this video, Dr. Chandler explains what her Branch does and the ways in which her work is rewarding. The chief of NIDA's Services Research Branch talks about drug abuse...

Animation: Building an Anti-Drug Vaccine

 |  The immune system has an extraordinary ability to recognize compounds foreign to the body and eliminate them. NIDA-sponsored scientists are working to harness this ability to create vaccines that will...

Q&A: Dr. David Thomas

 |  Dr. David Thomas, a Program Officer in NIDA’s Behavioral and Cognitive Science Research Branch, speaks about the intertwined problems of pain and prescription opioid abuse. In this video, Dr. David...

Training Gaps for Evidence-Based Practices

 |  Bar graph shows that cognitive-behavioral therapy is used at more privately funded substance abuse treatment programs than three other evidence-based treatments: motivational interviewing, contingency management, and brief strategic family

The Present and Promise of mHealth

 |  Only 15 percent of people who need drug abuse treatment seek help, in part because it is difficult to take the first step. Responding to this issue, NIDA researchers have...

Financial Strain Hinders Smoking Cessation

 |  Incorporating measures to help patients deal with financial strain might improve success rates of antismoking interventions, say researchers at the University of Texas M.D. Anderson Cancer Center. In a clinical...

Substance Abuse Among Older Adults

 |  The percentage of American 50- to 59-year-olds who reported having abused illicit or prescription drugs during the past year more than doubled, from 2.7 percent to 6.2 percent, between 2002...

Nanotechnology Powers Smart Skin Patch

 |  NIDA-funded researchers have conducted a successful in vitro demonstration of a prototype programmable medication skin patch. As envisioned by developers Drs. Bruce Hinds and Audra Stinchcomb of the University of...

Good-Bye, Paper

 |  Starting in early 2012, after 25 years in print, NIDA Notes will become exclusively a Web publication. In its dynamic new format, NIDA Notes will continue to provide the same...

Grantee Wins Early Career Award

 |  Dr. Mauricio R. Delgado of Rutgers University in Newark. NIDA grantee Dr. Mauricio R. Delgado of Rutgers University in Newark, New Jersey, received a 2010 Presidential Early Career Award for...

Office Meets Dynamic Challenges of Diversity

 |  Although drug abuse touches the lives of people from all racial and ethnic backgrounds, its consequences are borne unequally. Members of minority populations often experience far worse outcomes than whites...

Intensive Interventions Reduce Risky Sexual Behaviors

 |  Multi-session motivational and behavioral training targeted specifically to men or women can cut substance abusers' high-risk sexual behaviors more effectively and enduringly than a typical single preventive educational intervention. In...

Teenage Marijuana Use Is on the Rise

 |  A growing percentage of students in the 8th, 10th, and 12th grades are using marijuana on a regular basis, according to the 2010 Monitoring the Future (MTF) survey. Most notably...

Two NIDA Grantees Receive Sarnat Prize

 |  Two prominent addiction scientists—Dr. Eric J. Nestler and Dr. Charles P. O'Brien—received the 2010 Rhoda and Bernard Sarnat International Prize in Mental Health. The Institute of Medicine presented the prize...